Drugs / NPH
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05614089 Comparator | Mar 2023 → Aug 2024 | type 1 diabetes mellitus | Jing Luo | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NPH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05614089 ↗ |
| Modality | Protein / enzyme biologic | “human isophane insulin” PMID 42409045 ↗ Jul 2026 |